Observatory · observe first
Regeneron Pharmaceuticals
REGN · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.148%
12M weight contribution
+0.025 pp
3M weight contribution
-0.017 pp
12M price return
-28.7%
Share of matched S&P 500 members
Monthly observations through Aug 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Aug 2019 | $27.3bn | 0.148% | +0.025 pp | -28.7% | No |
| Jul 2019 | $28.6bn | 0.152% | -0.049 pp | -17.2% | No |
| Jun 2019 | $29.4bn | 0.159% | -0.038 pp | -9.3% | No |
| May 2019 | $28.3bn | 0.165% | -0.006 pp | +0.5% | No |
| Apr 2019 | $32.2bn | 0.180% | +0.004 pp | +13.0% | Yes |
| Mar 2019 | $38.6bn | 0.222% | +0.023 pp | +19.2% | Yes |
| Feb 2019 | $40.5bn | 0.235% | +0.054 pp | +34.4% | Yes |
| Jan 2019 | $40.3bn | 0.133% | -0.063 pp | +17.1% | Yes |
| Dec 2018 | $35.1bn | 0.125% | -0.071 pp | +1.9% | No |
| Nov 2018 | $34.4bn | 0.114% | -0.082 pp | -0.3% | No |
| Oct 2018 | $31.9bn | 0.108% | -0.088 pp | -7.5% | No |
| Sep 2018 | $38.0bn | 0.121% | -0.076 pp | +10.2% | No |
| Aug 2018 | $38.2bn | 0.123% | -0.073 pp | +10.9% | No |
| Jul 2018 | $34.6bn | 0.202% | +0.005 pp | +0.4% | Yes |
| Jun 2018 | $32.4bn | 0.197% | +0.000 pp | -5.9% | Yes |
| May 2018 | $28.2bn | 0.171% | -0.025 pp | -18.1% | No |
| Apr 2018 | $28.5bn | 0.175% | -0.021 pp | -17.2% | No |
| Mar 2018 | $32.4bn | 0.199% | +0.002 pp | -6.1% | Yes |
| Feb 2018 | $30.1bn | 0.180% | -0.016 pp | -12.6% | No |
| Jan 2018 | $34.4bn | 0.196% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.